DeFi Technologies (NASDAQ:DEFT) and BR Biopharma (NASDAQ:BRBI) Financial Analysis

BR Biopharma (NASDAQ:BRBI – Get Free Report) and DeFi Technologies (NASDAQ:DEFT – Get Free Report) are both small-cap finance companies, but which is the superior business? We will compare the two companies based on the strength of their earnings, analyst recommendations, institutional ownership, dividends, profitability, valuation and risk.

Analyst Recommendations

This is a breakdown of recent recommendations and price targets for BR Biopharma and DeFi Technologies, as reported by MarketBeat.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
BR Biopharma 1 1 0 0 1.50
DeFi Technologies 0 2 3 0 2.60

DeFi Technologies has a consensus price target of $1.44, suggesting a potential upside of 259.38%. Given DeFi Technologies’ stronger consensus rating and higher possible upside, analysts clearly believe DeFi Technologies is more favorable than BR Biopharma.

Profitability

This table compares BR Biopharma and DeFi Technologies’ net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
BR Biopharma N/A N/A N/A
DeFi Technologies 39.65% 15.43% 2.64%

Earnings & Valuation

This table compares BR Biopharma and DeFi Technologies”s gross revenue, earnings per share and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
BR Biopharma $2.23 billion 0.04 $31.36 million $0.08 96.50
DeFi Technologies $99.14 million 1.57 $62.41 million $0.06 6.67

DeFi Technologies has lower revenue, but higher earnings than BR Biopharma. DeFi Technologies is trading at a lower price-to-earnings ratio than BR Biopharma, indicating that it is currently the more affordable of the two stocks.

Summary

DeFi Technologies beats BR Biopharma on 8 of the 10 factors compared between the two stocks.

About BR Biopharma

(Get Free Report)

BRBI BR Partners S.A., through its subsidiaries, operates as an investment bank which specializes in providing financial services for entrepreneurs and families principally in Brazil. It offers financial advisory services for mergers and acquisitions, capital markets, board services, shareholders, special situations and restructuring, pre-IPO, and privatization; and wealth management services. BRBI BR Partners S.A. is based in S?o Paulo, Brazil.

About DeFi Technologies

(Get Free Report)

DeFi Technologies, Inc. engages in the provision of investment services. It plans to acquire equity, debt, or other securities of publicly traded or private companies or other entities. The firm offers DeFi ETNs, DeFi Governance, DeFi Venture and DeFi Treasury. The company was founded by Olivier Francois Roussy Newton and Wouter Witvoet on April 14, 1986 and is headquartered in Toronto, Canada.

Receive News & Ratings for BR Biopharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BR Biopharma and related companies with MarketBeat.com's FREE daily email newsletter.